{"id":"NCT01010932","sponsor":"Guerbet","briefTitle":"Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)","officialTitle":"Evaluation of Dotarem-enhanced MRA Compared to Time-Of-Flight (TOF) MRA in the Diagnosis of Carotid and Vertebral Basilar Arterial Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10","primaryCompletion":"2010-12","completion":"2010-12","firstPosted":"2009-11-10","resultsPosted":"2015-08-25","lastUpdate":"2016-06-16"},"enrollment":222,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Cerebral Arterial Diseases"],"interventions":[{"type":"DRUG","name":"Dotarem","otherNames":["Gadoterate meglumine"]},{"type":"OTHER","name":"TOF MRA","otherNames":[]}],"arms":[{"label":"Dotarem and TOF MRA","type":"EXPERIMENTAL"}],"summary":"The study will evaluate the efficacy and safety of Dotarem enhanced MRA in patients suffering from carotid or vertebral arterial disease.","primaryOutcome":{"measure":"Technical Failure Rate","timeFrame":"2 - 28 days","effectByArm":[{"arm":"Dotarem-enhanced MRA","deltaMin":4.65,"sd":null},{"arm":"TOF MRA","deltaMin":29.44,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":200},"commonTop":["Hypertension","Injection site hematoma","Nausea","Dizziness","Headache"]}}